Adriaan A Voors Selected Research

Furosemide (Lasix)

1/2022	Worsening renal function in acute heart failure in the context of diuretic response.
1/2019	Very Early Diuretic Response After Admission for Acute Heart Failure.
10/2017	Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
6/2017	Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
2/2016	A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
2/2016	Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
10/2015	Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response.
9/2015	Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
8/2015	Diuretic response in acute heart failure-an analysis from ASCEND-HF.
5/2014	Diuretic response in acute heart failure: clinical characteristics and prognostic significance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adriaan A Voors Research Topics

Disease

345	Heart Failure 10/2022 - 07/2004
32	Myocardial Infarction 01/2022 - 12/2004
23	Inflammation (Inflammations) 01/2022 - 08/2006
18	Renal Insufficiency (Renal Failure) 11/2020 - 09/2005
15	Atrial Fibrillation 10/2021 - 01/2010
14	Iron Deficiencies 01/2022 - 04/2013
13	Hypertension (High Blood Pressure) 12/2019 - 05/2007
12	Dyspnea (Shortness of Breath) 08/2020 - 01/2010
11	Anemia 11/2021 - 09/2005
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 12/2002
9	Systolic Heart Failure 01/2021 - 01/2011
9	Diabetes Mellitus 01/2021 - 03/2012
8	Weight Loss (Weight Reduction) 01/2022 - 05/2013
8	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2017
8	Heart Diseases (Heart Disease) 01/2020 - 10/2013
8	Stroke (Strokes) 01/2020 - 05/2007
7	Hypotension (Low Blood Pressure) 01/2022 - 08/2015
7	Chronic Renal Insufficiency 01/2022 - 01/2014
7	Fibrosis (Cirrhosis) 01/2021 - 09/2009
7	Left Ventricular Dysfunction 01/2018 - 01/2011
6	Necrosis 01/2022 - 12/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2005
6	Neoplasms (Cancer) 01/2022 - 09/2009
6	Pulmonary Hypertension 11/2021 - 10/2015
6	Body Weight (Weight, Body) 01/2019 - 05/2011
6	Infarction (Infarctions) 10/2013 - 03/2005
5	Hypertrophy 01/2020 - 07/2005
5	ST Elevation Myocardial Infarction 01/2016 - 08/2010
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2015
4	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 07/2006
4	Atherosclerosis 01/2020 - 07/2007
4	Hyperkalemia 11/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

59	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
58	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 03/2006
26	DiureticsIBA 01/2022 - 01/2011
25	pro-brain natriuretic peptide (1-76)IBA 11/2021 - 01/2005
25	Erythropoietin FDA Link 10/2021 - 02/2004
24	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 09/2004
20	Natriuretic PeptidesIBA 01/2021 - 01/2005
18	CreatinineIBA 01/2022 - 10/2006
15	vericiguatIBA 01/2022 - 01/2018
15	Angiotensin Receptor AntagonistsIBA 06/2021 - 07/2007
14	rolofyllineIBA 11/2019 - 05/2011
13	RelaxinIBA 12/2021 - 04/2009
12	SodiumIBA 01/2022 - 10/2013
12	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2022 - 11/2014
12	Urea (Carbamide)FDA LinkGeneric 01/2021 - 09/2013
11	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 05/2011
10	Pharmaceutical PreparationsIBA 10/2022 - 01/2010
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2010
10	Hemoglobins (Hemoglobin)IBA 11/2021 - 04/2005
10	C-Reactive ProteinIBA 01/2021 - 06/2006
10	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 01/2011
10	NitrogenIBA 01/2017 - 09/2013
10	Advanced Glycation End ProductsIBA 11/2012 - 12/2007
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2007
9	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2013
9	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 08/2013
9	Troponin T (Troponin T1)IBA 11/2021 - 11/2011
9	AlbuminsIBA 06/2021 - 11/2006
9	Purinergic P1 Receptor AntagonistsIBA 11/2019 - 05/2011
9	MicroRNAs (MicroRNA)IBA 01/2018 - 05/2014
8	Growth Differentiation Factor 15IBA 01/2022 - 08/2013
8	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 07/2007
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2019 - 12/2004
7	Biological ProductsIBA 01/2022 - 08/2006
7	IronIBA 11/2019 - 01/2017
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2021
6	empagliflozinIBA 01/2022 - 01/2020
6	SymportersIBA 01/2022 - 10/2019
6	PotassiumIBA 01/2021 - 09/2014
6	TroponinIBA 01/2021 - 11/2011
6	Adenosine A1 ReceptorIBA 11/2019 - 05/2011
6	Ferritins (Ferritin)IBA 01/2018 - 04/2013
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2010 - 02/2004
5	Cardiac MyosinsIBA 01/2022 - 01/2016
5	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
5	omecamtiv mecarbilIBA 01/2022 - 01/2016
5	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 01/2014
5	Soluble Guanylyl CyclaseIBA 10/2020 - 03/2013
5	AdrenomedullinIBA 01/2020 - 06/2011
5	Transferrin (beta 2 Transferrin)IBA 01/2018 - 04/2013
5	Neprilysin (Neutral Endopeptidase)IBA 01/2017 - 08/2013
5	Galectin 3 (LGALS3)IBA 01/2016 - 09/2009
5	Valsartan (Vals)FDA Link 01/2016 - 08/2013
4	LigandsIBA 01/2022 - 03/2015
4	Lipocalin-2IBA 01/2022 - 10/2008
4	Fibroblast Growth Factor-23IBA 01/2022 - 01/2018
4	ChloridesIBA 12/2021 - 01/2016
4	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 05/2007
4	CholesterolIBA 01/2021 - 08/2006
4	ReninIBA 01/2020 - 05/2015
4	Angiotensin-Converting Enzyme 2IBA 01/2020 - 01/2020
4	Adenosine (Adenocard)FDA LinkGeneric 11/2018 - 05/2011

Therapy/Procedure

68	Therapeutics 08/2022 - 02/2004
25	Patient Readmission 01/2020 - 02/2012
13	Length of Stay 01/2021 - 01/2010
4	Percutaneous Coronary Intervention 01/2022 - 08/2010
4	Ligation 01/2018 - 08/2007
4	Renal Dialysis (Hemodialysis) 01/2018 - 10/2012